Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study
DOI: 10.1158/1078-0432.CCR-25-0210
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Kerry A. Rogers; Pearlly Yan; Ian W. Flinn; Deborah M. Stephens; Thomas J. Kipps; Sarah M. Larson; Laura Martz; Xi Chen; Huabao Wang; Ethan Hopping; Ralf Bundschuh; Altan Turkoglu; Gerard Lozanski; Carolyn McGarry; Alexandra Acosta; Romain Sechaud; Daniela Baldoni; Anwesha Chaudhury; Jeanne Whalen; Nadia B. Hassounah; Nina Orwitz; Javier Otero; Janghee Woo; John C. Byrd
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-25-0210/3668503/ccr-25-0210.pdf

